Literature DB >> 8326855

Distribution of a lipooligosaccharide-specific sialyltransferase in pathogenic and non-pathogenic Neisseria.

R E Mandrell1, J M Griffiss, H Smith, J A Cole.   

Abstract

Sialyltransferase activity has been detected in Triton X100 extracts of all examined strains of pathogenic Neisseria as well as in 17 out of 18 Neisseria lactamica isolates. The enzyme was detected both in strains able to synthesize the 4.5 kDa lipooligosaccharide (LOS) component known to be sialylated in vivo and in vitro by cytidine 5'-monophospho-N-acetylneuraminic acid, and in some strains which lack this component. Exogenous 4.5 kDa+ LOS was required to detect the sialyltransferase activity in strains which lacked the LOS component. Sialyltransferase activity in a serogroup A, L11 (4.5 kDa-) meningococcal strain sialylated exogenous purified LOS from gonococci. The meningococcal serogroup B and C strain sialyltransferases active with LOS acceptors appeared to be distinct from the sialyltransferase required for the synthesis of the meningococcal polysialic acid capsule.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326855     DOI: 10.1006/mpat.1993.1031

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.

Authors:  Hong Wu; Ann E Jerse
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.

Authors:  Sanjay Ram; Sunita Gulati; Lisa A Lewis; Srinjoy Chakraborti; Bo Zheng; Rosane B DeOliveira; George W Reed; Andrew D Cox; Jianjun Li; Frank St Michael; Jacek Stupak; Xiao-Hong Su; Sudeshna Saha; Corinna S Landig; Ajit Varki; Peter A Rice
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

3.  Influence of the length of the lipooligosaccharide alpha chain on its sialylation in Neisseria meningitidis.

Authors:  Chao-Ming Tsai; George Kao; Peixuan Zhu
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.

Authors:  W Melaugh; A A Campagnari; B W Gibson
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

5.  Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

Authors:  J S Swartley; J H Ahn; L J Liu; C M Kahler; D S Stephens
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

6.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

7.  Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity.

Authors:  M J Filiatrault; R S Munson; A A Campagnari
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

8.  Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae.

Authors:  M J Gill; D P McQuillen; J P van Putten; L M Wetzler; J Bramley; H Crooke; N J Parsons; J A Cole; H Smith
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase involved in the synthesis of UDP-GlcNAc.

Authors:  J Ullrich; J P van Putten
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

10.  Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  D S Stephens; C F McAllister; D Zhou; F K Lee; M A Apicella
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.